SCHEMBL9295022

SCHEMBL9295022

CCCCc1nc2ccc(C3(C)CC4CCCCN4O3)cc2c(=O)n1Cc1ccc(-c2ccccc2-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGT P01019 4/20 0.72
AGTR1 P30556 1/20 0.72
AGTR2 P50052 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9295027 1.00 AGT (0.72) AGTAGTR1AGTR2
SCHEMBL9295706 1.00 AGT (0.72) AGTAGTR1AGTR2
SCHEMBL9295066 0.98 AGT (0.74) AGTAGTR1AGTR2
SCHEMBL9295030 0.98 AGT (0.74) AGTAGTR1AGTR2
SCHEMBL9294927 0.98 AGT (0.74) AGTAGTR1AGTR2
SCHEMBL9294944 0.98 AGT (0.74) AGTAGTR1AGTR2
SCHEMBL9295430 0.91 AGT (0.64) AGTAGTR1AGTR2
SCHEMBL9295424 0.91 AGT (0.64) AGTAGTR1AGTR2
SCHEMBL9295226 0.91 AGTR1 (0.65) AGTAGTR1AGTR2
SCHEMBL9295031 0.91 AGTR1 (0.65) AGTAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5358951-A Treating hypertension, congestive heart failure AMERICAN CYANAMID COMPANY (US) 1994-10-25 US claimed
EP-0621276-A1 Angiotensin II receptor blocking 2,3,6-substituted quinazolinones AMERICAN CYANAMID COMPANY (US) 1994-10-26 EP disclosed
US-5358951-A Treating hypertension, congestive heart failure AMERICAN CYANAMID COMPANY (US) 1994-10-25 US disclosed
US-5292734-A Angiotensin II receptor blocking 2,3,6 substituted quinazolinones AMERICAN CYANAMID COMPANY (US) 1994-03-08 US disclosed